Literature DB >> 19124750

Cell-mediated immunity to Toxoplasma gondii develops primarily by local Th1 host immune responses in the absence of parasite replication.

Jason P Gigley1, Barbara A Fox, David J Bzik.   

Abstract

A single inoculation of mice with the live, attenuated Toxoplasma gondii uracil auxotroph strain cps1-1 induces long-lasting immunity against lethal challenge with hypervirulent strain RH. The mechanism for this robust immunity in the absence of parasite replication has not been addressed. The mechanism of long-lasting immunity, the importance of route of immunization, cellular recruitment to the site of infection, and local and systemic inflammation were evaluated. Our results show that infection with cps1-1 elicits long-lasting CD8+ T cell- mediated immunity. We show that immunization with cps1-1-infected dendritic cells elicits long-lasting immunity. Intraperitoneal infection with cps1-1 induced a rapid influx of GR1+ neutrophils and two stages of GR1+CD68+ inflammatory monocyte infiltration into the site of inoculation. CD19+ B cells and CD3+ T cells steadily increase for 8 days after infection. CD8+ T cells were rapidly recruited to the site of infection and increased faster than CD4+ T cells. Surprisingly, cps1-1 infection induced high systemic levels of bioactive IL-12p70 and a very low level and transient systemic IFN-gamma. Furthermore, we show significant levels of these inflammatory cytokines were locally produced at the site of cps1-1 inoculation. These findings offer new insight into immunological mechanisms and local host responses to a non-replicating type I parasite infection associated with development of long-lasting immunity to Toxoplasma gondii.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19124750      PMCID: PMC2615398          DOI: 10.4049/jimmunol.182.2.1069

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  71 in total

1.  Toxoplasma gondii: evidence for interleukin-12-dependent and-independent pathways of interferon-gamma production induced by an attenuated parasite strain.

Authors:  T Scharton-Kersten; P Caspar; A Sher; E Y Denkers
Journal:  Exp Parasitol       Date:  1996-11       Impact factor: 2.011

2.  In the absence of endogenous IFN-gamma, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection.

Authors:  T M Scharton-Kersten; T A Wynn; E Y Denkers; S Bala; E Grunvald; S Hieny; R T Gazzinelli; A Sher
Journal:  J Immunol       Date:  1996-11-01       Impact factor: 5.422

3.  Interleukin-12 antagonist activity of mouse interleukin-12 p40 homodimer in vitro and in vivo.

Authors:  M K Gately; D M Carvajal; S E Connaughton; S Gillessen; R R Warrier; K D Kolinsky; V L Wilkinson; C M Dwyer; G F Higgins; F J Podlaski; D A Faherty; P C Familletti; A S Stern; D H Presky
Journal:  Ann N Y Acad Sci       Date:  1996-10-31       Impact factor: 5.691

4.  Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts.

Authors:  R T Gazzinelli; S Hieny; T A Wynn; S Wolf; A Sher
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

5.  Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii.

Authors:  R Gazzinelli; Y Xu; S Hieny; A Cheever; A Sher
Journal:  J Immunol       Date:  1992-07-01       Impact factor: 5.422

6.  A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene.

Authors:  D Kitamura; J Roes; R Kühn; K Rajewsky
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

7.  Murine CD8+ cytotoxic T lymphocytes lyse Toxoplasma gondii-infected cells.

Authors:  C S Subauste; A H Koniaris; J S Remington
Journal:  J Immunol       Date:  1991-12-01       Impact factor: 5.422

8.  CD8+ T cells from mice vaccinated against Toxoplasma gondii are cytotoxic for parasite-infected or antigen-pulsed host cells.

Authors:  F T Hakim; R T Gazzinelli; E Denkers; S Hieny; G M Shearer; A Sher
Journal:  J Immunol       Date:  1991-10-01       Impact factor: 5.422

9.  Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii.

Authors:  R T Gazzinelli; M Wysocka; S Hayashi; E Y Denkers; S Hieny; P Caspar; G Trinchieri; A Sher
Journal:  J Immunol       Date:  1994-09-15       Impact factor: 5.422

10.  Antigen-pulsed dendritic cells can efficiently induce an antibody response in vivo.

Authors:  T Sornasse; V Flamand; G De Becker; H Bazin; F Tielemans; K Thielemans; J Urbain; O Leo; M Moser
Journal:  J Exp Med       Date:  1992-01-01       Impact factor: 14.307

View more
  47 in total

1.  Kinetics and phenotype of vaccine-induced CD8+ T-cell responses to Toxoplasma gondii.

Authors:  Kimberly A Jordan; Emma H Wilson; Elia D Tait; Barbara A Fox; David S Roos; David J Bzik; Florence Dzierszinski; Christopher A Hunter
Journal:  Infect Immun       Date:  2009-06-15       Impact factor: 3.441

2.  Use of transgenic parasites and host reporters to dissect events that promote interleukin-12 production during toxoplasmosis.

Authors:  David A Christian; Anita A Koshy; Morgan A Reuter; Michael R Betts; John C Boothroyd; Christopher A Hunter
Journal:  Infect Immun       Date:  2014-07-14       Impact factor: 3.441

3.  Virulence of Toxoplasma gondii is associated with distinct dendritic cell responses and reduced numbers of activated CD8+ T cells.

Authors:  Elia D Tait; Kimberly A Jordan; Christopher D Dupont; Tajie H Harris; Beth Gregg; Emma H Wilson; Marion Pepper; Florence Dzierszinski; David S Roos; Christopher A Hunter
Journal:  J Immunol       Date:  2010-06-30       Impact factor: 5.422

4.  Pyrimidine Pathway-Dependent and -Independent Functions of the Toxoplasma gondii Mitochondrial Dihydroorotate Dehydrogenase.

Authors:  Miryam Andrea Hortua Triana; Daniela Cajiao Herrera; Barbara H Zimmermann; Barbara A Fox; David J Bzik
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

5.  The IL-12- and IL-23-Dependent NK Cell Response Is Essential for Protective Immunity against Secondary Toxoplasma gondii Infection.

Authors:  Daria L Ivanova; Tiffany M Mundhenke; Jason P Gigley
Journal:  J Immunol       Date:  2019-10-11       Impact factor: 5.422

6.  Role of CD4+ Foxp3+ Regulatory T Cells in Protection Induced by a Live Attenuated, Replicating Type I Vaccine Strain of Toxoplasma gondii.

Authors:  Haroon Akbar; Isabelle Dimier-Poisson; Nathalie Moiré
Journal:  Infect Immun       Date:  2015-06-29       Impact factor: 3.441

7.  Immune-mediated regression of established B16F10 melanoma by intratumoral injection of attenuated Toxoplasma gondii protects against rechallenge.

Authors:  Jason R Baird; Katelyn T Byrne; Patrick H Lizotte; Seiko Toraya-Brown; Uciane K Scarlett; Matthew P Alexander; Mee Rie Sheen; Barbara A Fox; David J Bzik; Marcus Bosenberg; David W Mullins; Mary Jo Turk; Steven Fiering
Journal:  J Immunol       Date:  2012-12-07       Impact factor: 5.422

8.  Human immunome, bioinformatic analyses using HLA supermotifs and the parasite genome, binding assays, studies of human T cell responses, and immunization of HLA-A*1101 transgenic mice including novel adjuvants provide a foundation for HLA-A03 restricted CD8+T cell epitope based, adjuvanted vaccine protective against Toxoplasma gondii.

Authors:  Hua Cong; Ernest J Mui; William H Witola; John Sidney; Jeff Alexander; Alessandro Sette; Ajesh Maewal; Rima McLeod
Journal:  Immunome Res       Date:  2010-12-03

9.  Immunity in the spleen and blood of mice immunized with irradiated Toxoplasma gondii tachyzoites.

Authors:  Nahiara Esteves Zorgi; Andrés Jimenez Galisteo; Maria Notomi Sato; Nanci do Nascimento; Heitor Franco de Andrade
Journal:  Med Microbiol Immunol       Date:  2016-01-05       Impact factor: 3.402

10.  Avirulent Toxoplasma gondii generates therapeutic antitumor immunity by reversing immunosuppression in the ovarian cancer microenvironment.

Authors:  Jason R Baird; Barbara A Fox; Kiah L Sanders; Patrick H Lizotte; Juan R Cubillos-Ruiz; Uciane K Scarlett; Melanie R Rutkowski; Jose R Conejo-Garcia; Steven Fiering; David J Bzik
Journal:  Cancer Res       Date:  2013-05-23       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.